Jul 30 |
Zacks Industry Outlook Highlights Moderna, Sarepta Therapeutics, Halozyme Therapeutics, Krystal Biotech and Axsome Therapeutics
|
Jul 29 |
5 Biotech Stocks to Bet On Bright Industry Prospects
|
Jul 29 |
Exploring Analyst Estimates for Moderna (MRNA) Q2 Earnings, Beyond Revenue and EPS
|
Jul 29 |
RSV vaccine makers vying for market share in second year of shots
|
Jul 27 |
RSV vaccine market to decline 64% on CDC decision: report
|
Jul 26 |
Moderna (MRNA) Stock Before Q2 Earnings: To Buy or Not to Buy?
|
Jul 26 |
Beam Therapeutics (BEAM) Soars 7.9%: Is Further Upside Left in the Stock?
|
Jul 26 |
Moderna Insiders Sell US$3.3m Of Stock, Possibly Signalling Caution
|
Jul 26 |
This Biotech Risk-Taker Created Moderna. Now He’s Harnessing AI.
|
Jul 24 |
Novartis invests in bispecifics for cancer; Bob Langer steps down from Moderna board
|